The largest database of trusted experimental protocols

Zinc protoporphyrin

Zinc protoporphyrin is a metalloporphyrin that serves as an important biochemical marker for various medical conditions.
It is a competitive inhibitor of ferrochelatase, the enzyme responsible for the insertion of iron into protoporphyrin IX during heme biosynthesis.
Elevated levels of zinc protoporphyrin are observed in iron deficiency anemia, lead poisoning, and certain hemolytic disorders.
This molecule has potential applications in the diagnosis and monitoring of these conditions.
Researchers can utilize PubCompare.ai's AI-driven platform to optimize research protocols and locate the best zinc protoporphyrin-related studies from literature, pre-prints, and patents through intelligent comparisons, improving research outcomes with this innovative solution.

Most cited protocols related to «Zinc protoporphyrin»

This investigation of maternal and child risk factors for IDA was approved by the University of Wisconsin and Meriter Institutional Review Boards. English and Spanish speaking women, 18-40 years of age, delivering newborns ≥35 weeks of gestation at Meriter Hospital were eligible to participate. Consent was obtained from those with ≥1 medical or demographic risk factors for depleted newborn or infant iron status, including prenatally diagnosed maternal IDA, pre-gestational or gestational diabetes mellitus, SGA or LGA newborns, maternal ethnic minority (African-American, Latina or Asian), or low socioeconomic status, using the surrogate of self-pay or Medicaid. Specimens from a total of 309 newborns with 1 or more risk factors were analyzed. Although not a previously reported risk factor nor criterion for enrollment, we included maternal BMI >30 kg/m2 as a risk factor in our analysis is because it predisposes to maternal IDA, gestational diabetes, and fetal overgrowth, all risk factors for depletion of newborn iron stores. To provide a reference comparison, we generated cord blood laboratory data from a recent representative population of 188 healthy newborns born at ≥35 weeks of gestation, delivered from mothers of all ethnic backgrounds at Meriter Hospital without other known risk factors for IDA.6 (link),10 (link),11 (link)Umbilical blood collected at delivery, stored at 4° C, was assayed within 8 days. Complete blood cell counts were performed by pocH-100i (Sysmex, Mundelein, IL). After washing to remove pigments, cord zinc protoporphyrin/heme (ZnPP/H) was measured with Front-Face Hematofluorometry (Aviv Biomedical Co., Lakewood, NJ).11 (link) Reticulocyteenriched ZnPP/H (RE-ZnPP/H) was measured from the lightest 6.25% of cells to assess ZnPP/H in recently-made erythrocytes.11 (link) Serum ferritin (Bio-Quant, San Diego, CA) was assessed as an index of storage iron and serum transferrin (Immunology Consultants Lab, Newberg, OR) determined as a reflection of transport iron.
The 2 study groups of interest were demarcated as either high-risk (≥3 risk factors) or medium-risk (1-2 risk factors), and compared to the control neonates born to mothers without designated risk factors. Birth weight was z-scored for gestational age, and used to ascertain whether the neonate exceeded the criterion for LGA as >2 or SGA as <−2.10 (link),12 (link) One-way and multiple ANOVA with Fisher post hoc testing were used to compare differences between the groups and the Pearson test was used to evaluate correlations between outcome measures. Chi square analysis was used for nominal demographic variables. The alpha value for statistical significance was set at p<0.05. Natural log conversions were applied to normalize the distribution of ZnPP/H, RE-ZnPP/H and ferritin values. The data portrayed in figures are the mean ± SEM.
Publication 2012
Cord blood samples from three separate groups of newborns were analyzed. EDTA-anticoagulated cord blood is normally collected at all deliveries in the Birthing Center at Meriter Hospital, Madison, WI, U.S.A. and held for 7 days in the Blood Bank. We obtained the blood just before samples were to be discarded. Blood was obtained between June 2005 and December 2006. The term control group was randomly collected from normal term deliveries. The second group, offspring of term/near-term insulin-treated diabetes (IDM), was collected because of the marked risk for abnormal iron status (4 (link), 8 (link)). IDM newborns admitted to the NICU are more severely affected by maternal illness. The intent of the third, at-risk group was to obtain cord blood from term ethnic minority and Caucasian mothers exhibiting intermediate iron status. From the at-risk group, we defined a mild ID subset with cord plasma ferritin values in the lowest quartile of our samples, but normal cord whole blood ZnPP/H (10 (link)). The fourth, premature group included cord blood from newborns with birth weight less than 1500 g, but without known impairment of iron status by maternal diabetes or growth restriction. Because cord ZnPP/H ratios in premature normally fall as gestation increases (4 (link), 8 (link)), this group was included to determine whether Δ ZnPP/H is observed in premature newborns. The premature and IDM groups were identified from the Meriter Hospital Nursery Intensive Care Unit (NICU) admission log and the at-risk group from the healthy newborn admission log. No other data were collected from these mother-child dyads. Approvals from the UW-Madison Human Subjects Committee and Meriter Hospital Institutional Review Board were obtained to analyze deidentified samples.
Publication 2008
ARID1A protein, human Birth Weight BLOOD Caucasoid Races Child Cone-Rod Dystrophy 2 Diabetes Mellitus Edetic Acid Ethics Committees, Research Ethnic Minorities Ferritin Gestational Diabetes Homo sapiens Infant, Newborn Insulin Iron Mothers Obstetric Delivery Plasma Population at Risk Pregnancy Premature Birth Umbilical Cord Blood zinc protoporphyrin
Infant iron status was based on cord blood at birth and venous blood at 9 months. Serum ferritin was assayed by electro-chemiluminescent immunoassay (Cobas 6000-601, Roche Diagnostics Corp., Basel, Switzerland), mean corpuscular volume (MCV) and red cell distribution width (RDW) by autoanalyzer (Sysmex SE-9000 Auto Hematology Analyzer, Kobe, Japan), and zinc protoporphyrin/heme ratio (ZPP/H) by ZPP Hematofluorometer (Model 206D, AVIV Associates, Lakewood, NJ).
There is no consensus on how to define ID in the neonate. Therefore, we considered either low cord ferritin or high ZPP/H as indicative of prenatal ID. We used serum ferritin <75 μg/L as the cutoff for fetal–neonatal ID, as in some previous studies (Amin, Orlando, & Wang, 2013 (link); Armony-Sivan, Eidelman, Lanir, Sredni, & Yehuda, 2004 (link); Tamura et al., 2002 (link)). For prenatal ZPP/H, we used a cutoff of ZPP/H >118 μmol/mol, corresponding to the 90th percentile in the US studies (McLimore et al., 2013 (link)).
Postnatal ID was defined as two or more abnormal iron measures, a widely used standard in the field (Cook & Finch, 1979 (link)). The following age-appropriate cutoffs were used for four measures: MCV <74 fl (Centers for Disease Control, 2001 ), RDW >14.5% (Centers for Disease Control and Prevention, 1998 (link)), serum ferritin <12.0 (Saarinen & Siimes, 1978 ), and ZPP/H >69 μmol/mol heme (Soldin, Miller, & Soldin, 2003 (link)). These cutoffs are based on normative samples in healthy term infants from iron-supplemented populations or studies that excluded infants with evidence of ID. The rationale in these studies is that reference values for iron measures should be based on infants who have access to adequate iron, as data from populations where ID is common will shift the distributions and likely underestimate ID prevalence and fail to identify infants who could benefit from intervention.
The possible combinations of pre- and postnatal ID constituted the four study groups: pre- and postnatal ID, prenatal ID only, postnatal ID only, and not ID at either time.
Publication 2015
Birth Cone-Rod Dystrophy 2 Diagnosis Erythrocyte Volume, Mean Cell Ferritin Fetus Finches Heme Immunoassay Infant Infant, Newborn Iron Population Health Red Cell Distribution Width Serum Umbilical Cord Blood Veins zinc protoporphyrin

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
We identified all papers published on or before December 2010 that reported air or blood lead measurements that had been collected from US work sites that contained information on job or industry by searching the web-based bibliographic databases MEDLINE, Web of Science, Scopus, SciFinder, and NIOSHTIC2 using the search terms ‘lead exposure’, ‘worker’, ‘occupation’, and ‘occupational exposure’ and by reviewing the citations of the identified papers.
From each paper, we extracted lead measurements, which were primarily reported as summary statistics (including results presented in figures), and corresponding ancillary data. We excluded blood zinc protoporphyrin and free erythrocyte protoporphyrin measurements because these tests are not specific to lead [Baxter and Igisu 2010 ], pre-employment baseline biologic measurements, post-medical removal biologic measurements, and subsequent reports of data reported in multiple papers.
Air and blood lead concentrations were entered using units of µg/m3 and µg/dL, respectively, using conversion factor 1.0 µmol/L=20.7 µg/dL. If the number of measurements was provided as a range, the mean number was used in descriptive statistics and analyses. The three air summary statistics reported as below the limit of detection (LOD) were replaced with the LOD/2. Individual measurements in the same job/facility were aggregated. Missing arithmetic means (AM) were calculated from the geometric mean (GM) and geometric standard deviation (GSD) using equation 1. Missing GMs were assigned the median, if reported. Missing GMs and GSDs were calculated using equations 2 and 3, respectively, if the range was reported, then the AM was calculated using equation 1. If missing the GSD but the GM was available, we assumed a GSD =2.56 [Kromhout, et al. 1993 (link)].
AM=GM×exp[12×(ln(GSD))2]
ln(GM)=[ln(max)+ln(min)]2
ln(GSD)=[ln(max)ln(min)]4
Extracted ancillary data included exposure category, industry, job, task or area description, sample year (if a range, the midpoint was assigned; if missing, assigned publication year minus 2), exposure source, sample type, sampling method, analytic method, type of ventilation used, type of respiratory protection used, whether measurements represented worse case exposure scenarios (e.g., elevated blood lead levels, employee concerns, regulatory violations), whether the work being performed was a lead-based paint removal activity, and whether workplace containment structures were erected. Industry was coded to two-digit 1987 Standard Industrial Classification (SIC) codes [OMB 1987 ]. For air measurements, we extracted sampler location, whether the sample was task-based or full-shift, sampling duration, and particle size. For blood measurements, we extracted the time of sampling.
Hereafter, we focus on personal air and blood lead measurements because they are considered the preferred measures of personal lead exposure [ACGIH 2001 ]. To facilitate broad comparisons, we calculated industry-specific weighted arithmetic means (WAM≥1970, weighted by the number of measurements) for all personal air and blood lead summary statistics collected from 1970 onwards. Personal air WAM≥1970 calculations were restricted to total suspended particle and inhalable particle samples with sample durations >1 hour and that reported the number of measurements collected. WAMs≥1970 are reported here only for industries with ≥10 measurements. Statistical modeling of these data is reported separately.
Publication 2015
BAD protein, human Biopharmaceuticals BLOOD Erythrocytes Fibrinogen Fingers Occupational Exposure Protoporphyrins Respiratory Rate Workers zinc protoporphyrin

Most recents protocols related to «Zinc protoporphyrin»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
Nickel(II) phthalocyanine, Nickel(II) 2,9,16,23-tetraphenoxy-29H-31H-phthalocyanine, Copper(II) phthalocyanine, and Zinc(II) protoporphyrin IX were prepared at 1 mg/mL concentration in THF. For cobalt chloride (II) protoporphyrin IX, a 0.5 mg/mL solution was prepared since it tended to precipitate at higher concentrations. For MALDI analyses, 5 μL of the resulting solutions were mixed with an equal volume of each matrix solution (DAN, DCTB, TER, CHCA, and CClCA, 5 mg/mL in acetone); 1 μL of this solution was then spotted onto a MALDI plate and allowed to dry. Analyses also in LDI modality were carried out by depositing 1 μL of each standard solution directly on the target.
Full text: Click here
Publication 2024

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
Water, acetone, acetonitrile, trifluoroacetic acid (TFA), 2,2′:5′,2″-terthiophene (TER), 1,5-diaminonapthalene (DAN), trans-2-[3-(4-t-butyl-phenyl)-2-methyl-2-propenylidene]malononitrile (DCTB), 4-hydroxy-α-cyano cinnamic acid (CHCA), 4-chloro-α-cyano cinnamic acid (CClCA), Nickel(II) phthalocyanine (NiPc), Nickel(II) 2,9,16,23-tetraphenoxy-29H-31H-phthalocyanine (NiPcPhe), Cu(II) phthalocyanine (CuPc), Zinc(II) Protoporphyrin IX (ZnPP), Cobalt chloride (II) Protoporphyrin IX (CoPP), cytochrome c (horse heart), myoglobin, human hemoglobin, and proteomic-grade trypsin, were obtained from Sigma-Aldrich (Milan, Italy). Livers of cod and bovine as well as mussel were purchased from a local supermarket. Plasma was drawn from a healthy voluntary subject. All solvents used were LC–MS grade. A mass standards kit containing bradykinin (2–9 clip), angiotensin I, glu1-fibrinopeptide, ACTH (1–17, 18–39, 7–38 clips) for calibration was purchased from AB Sciex (Concord, ON, Canada).
Full text: Click here
Publication 2024
ARPE-19 cells (CRL-2302™) were cultured in Dulbecco’s Modified Eagle’s Medium/F-12 medium containing 10% fetal bovine serum as previously described (Park et al., 2022 (link)). Mangiferin and H2O2 (Sigma-Aldrich, St. Louis, MO, USA) were dissolved in dimethyl sulfoxide (Thermo Fisher Scientific, Waltham, MA, USA) to prepare stock solutions, diluted to appropriate concentrations in culture medium, and then treated with cells. To trigger oxidative stress, cells were cultured in medium containing H2O2, and Mangiferin and/or zinc protoporphyrin IX (ZnPP, Sigma-Aldrich) were added 1 h before H2O2 exposure.
Publication 2024

Top products related to «Zinc protoporphyrin»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Germany, United Kingdom, France, China, Japan, Austria, Sao Tome and Principe, Brazil, Italy, Canada, Norway, Sweden, Israel, Belgium, Poland, Cameroon, Netherlands, Switzerland, India
Hemin is a laboratory product that serves as a source of heme, the iron-containing cofactor found in various hemoproteins. It is commonly used in biochemical and cell culture applications for its role in heme-dependent processes.
Sourced in United States
Zinc protoporphyrin (ZnPP) is a laboratory product used for diagnostic and research purposes. It is a metalloporphyrin compound that can be used to measure heme metabolism and iron deficiency. ZnPP is a naturally occurring substance that can be detected and quantified in biological samples.
Sourced in United States, United Kingdom, China, Germany, Canada, Morocco, Japan, Italy, Switzerland, France, Israel, Singapore, Hong Kong, Sweden, Macao, Panama
β-actin is a cytoskeletal protein that is ubiquitously expressed in eukaryotic cells. It is a component of the microfilament system and plays a crucial role in various cellular processes, such as cell motility, maintenance of cell shape, and intracellular trafficking.
Sourced in United States
Zinc protoporphyrin IX (ZnPP) is a laboratory equipment product. It is a chemical compound with the formula C34H32N4O4Zn. ZnPP is used as a standard and reference material in various analytical and research applications.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Japan, Australia, Switzerland, Italy, Israel, Belgium, Austria, Spain, Brazil, Netherlands, Gabon, Denmark, Poland, Ireland, New Zealand, Sweden, Argentina, India, Macao, Uruguay, Portugal, Holy See (Vatican City State), Czechia, Singapore, Panama, Thailand, Moldova, Republic of, Finland, Morocco
Penicillin is a type of antibiotic used in laboratory settings. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Penicillin functions by disrupting the bacterial cell wall, leading to cell death.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Australia, Japan, Switzerland, Italy, Belgium, Israel, Austria, Spain, Netherlands, Poland, Brazil, Denmark, Argentina, Sweden, New Zealand, Ireland, India, Gabon, Macao, Portugal, Czechia, Singapore, Norway, Thailand, Uruguay, Moldova, Republic of, Finland, Panama
Streptomycin is a broad-spectrum antibiotic used in laboratory settings. It functions as a protein synthesis inhibitor, targeting the 30S subunit of bacterial ribosomes, which plays a crucial role in the translation of genetic information into proteins. Streptomycin is commonly used in microbiological research and applications that require selective inhibition of bacterial growth.
Sourced in United States, United Kingdom, China
Protoporphyrin IX zinc(II) (ZnPP) is a metalloporphyrin compound used as a laboratory reagent. It is the zinc(II) chelate of protoporphyrin IX, a naturally occurring tetrapyrrolic compound.
Sourced in United States, Germany, China, United Kingdom, Sao Tome and Principe, Macao, Italy, Japan, Canada, France, Switzerland, Israel, Australia, Spain, India, Ireland, Brazil, Poland, Netherlands, Sweden, Denmark, Hungary, Austria, Mongolia
The LPS laboratory equipment is a high-precision device used for various applications in scientific research and laboratory settings. It is designed to accurately measure and monitor specific parameters essential for various experimental procedures. The core function of the LPS is to provide reliable and consistent data collection, ensuring the integrity of research results. No further details or interpretations can be provided while maintaining an unbiased and factual approach.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.

More about "Zinc protoporphyrin"

Zinc protoporphyrin (ZnPP) is a metalloprotein that serves as an important biochemical marker for various medical conditions.
It is a competitive inhibitor of ferrochelatase, the enzyme responsible for the insertion of iron into protoporphyrin IX during heme biosynthesis.
Elevated levels of ZnPP are observed in iron deficiency anemia, lead poisoning, and certain hemolytic disorders like sickle cell disease and thalassemia.
ZnPP has potential applications in the diagnosis and monitoring of these conditions.
Researchers can utilize PubCompare.ai's AI-driven platform to optimize research protocols and locate the best ZnPP-related studies from literature, preprints, and patents through intelligent comparisons, improving research outcomes with this innovative solution.
ZnPP is closely related to other porphyrins like FBS (ferrochelatase), hemin, and protoporphyrin IX zinc(II) (ZnPP).
It is also influenced by factors like β-actin, penicillin, streptomycin, and LPS (lipopolysaccharide).
Understanding the interplay between these related terms and subtopics can provide valuable insights into the role of ZnPP in various medical contexts.
PubCompare.ai's platform enables researchers to navigate this complex landscape effectively, leading to more reproducible and accurate research outcomes.